Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

AdaptHealth Corp. (AHCO) had Revenue of $3.26B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$3.26B
Net Income	$82.75M
Cost of Goods Sold	$2.58B
Gross Profit	$681.09M
Operating Expenses	$3.00B
Operating Income	$263.73M
Non-Operating Income/Expense	$-127.71M
Pre-Tax Income	$136.02M
Normalized Pre-Tax Income	$136.02M
Income after Taxes	$94.78M
Income from Continuous Operations	$94.78M
Consolidated Net Income/Loss	$94.78M
Normalized Income after Taxes	$94.78M
EBIT	$263.73M
EBITDA	$647.81M
Weighted-Average Shares Outstanding (Basic)	133.76M
Weighted-Average Shares Outstanding (Diluted)	135.53M
Earnings per Share (EPS) (Basic)	$0.62
Earnings per Share (EPS) (Diluted)	$0.61
Balance Sheet Financials
Current Assets	$755.79M
Property, Plant, and Equipment	$474.56M
Long-Term Assets	$3.73B
Total Assets	$4.49B
Current Liabilities	$566.99M
Long-Term Debt	$1.99B
Long-Term Liabilities	$2.34B
Total Liabilities	$2.91B
Common Equity	$1.58B
Tangible Shareholders Equity	$-1.20B
Shareholders Equity	$1.58B
Common Shares Outstanding	134.60M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$541.84M
Cash Flow from Investing Activities	$-310.27M
Cash Flow from Financial Activities	$-198.95M
Beginning Cash	$77.13M
End Cash	$109.75M
Increase/Decrease in Cash	$32.62M
Stock-Based Compensation	$14.88M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.33
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.56
Debt to Equity Ratio	1.28
Gross Margin	20.89%
Operating Margin	8.09%
EBIT Margin	8.09%
EBITDA Margin	19.87%
Pre-Tax Profit Margin	4.17%
Profit Margin	2.54%
Free Cash Flow	$241.10M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.73
Inventory Turnover	18.45
Receiveable Turnover	7.99
Days Sales in Receivables	45.67
Return on Equity	6.01%
Return on Tangible Equity	-7.88%
Return on Assets	2.11%
Return on Investments	2.66%
Book Value Per Share	$11.72
Free Cash Flow per Share	$1.78
Operating Cash Flow per Share	$4.00

Data from Zacks Investment Research, Inc.